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1001-110 impact of Time to Reperfusion on Microvascular 
Damage After Primary Coronary Angioplasty for Acute 
Myocardial Infarction 
Takefumi Takahashi. Yoshikazu Hiasa, Takeshi Tomokane, Koji Yamaguchi, Riyo 
Oaura. Yoshikazu Ohara. Kanii Kusunoki. Kenichiro Yuba. Tatsuro Oaata. Shinobu 
1  
Hosokawa, Koichl Kishi, Ryuji Ohtani. Tokushima Red Cross Hospital, Komatsushima, 
Japan 
Backgrounds: A distinctive coronary flow velocity (CFV) pattern characterized by dimin- 
ished systolic antegrade flow and rapid diastolic deceleration rate (DDR) is thought to 
reflect a greater degree of microvascular damage in the risk area. We evaluated the 
impact of time to reperfusion on mlcrovascular damage after primary coronary angio- 
plasty for acute myocardlal infarction (AMI). 
Methods: We studied 73 patients with a first anterior wall myocardial infarction, without 
cardiogenic shock, who underwent primary coronary angioplasty within 12 hours (h) of 
onset. CFV parameters were assessed immediately after reperfusion using a Doppler 
guidewire. We measured systolic velocity integral (SVI) and DDR as makers of microvas- 
cular damage, according to the previous studies. 
Results: Reperfusion was achieved within 2 h in 9 patients (12%). SVI was significantly 
higher in patients with early reperfusion (~2 h vs. 4 to <6h and >/=6h, P = 0.003). Peak 
CPK was signtficantly lower in patients with early reperfusion (~2 h vs. 2 to c4 h, 4 to 
c6h. and >/=6h, P = 0.002). There were no differences in other clinical characteristtcs by 
time to repelfusion. 
Conclusions: Time to reperfusion, wcthln 2 h, is important for preventmg microvascular 
damage, which results in reduced infarct size. However, after 2 h, mkxovascular damage 
after primary coronary angioplasty is not dependent on time to reperfusion in patients 
with antenor AMI. 
CFV panmeters and chical results by tune to repefision 
<2h 2 to <4h 4 to <6h P value 
>/=6h 
(n=9. 12%) (n=36, 52%) (n=l3, 16%) (n=13, 16%) 
SVI, cm 3.6*1.7 2.2i2.6 0.5+1.&l 0.4i2.1 0.003 
DDR. cm/s& 37*19 126*101 139i132 143kl22 NS 
Peak CPK, IV/L 2041*1229 5402+2374 5500*3011 4667+1777 0.002 
LVEFat IM. % 66+10 53tll 55+15 54*11 0.04 
1001-111 Use of Glycoprotein llb/llla Receptor Blockers Before 
and During Percutaneous Coronary Intervention for 
Acute Coronary Syndromes Versus Stable Angina in 
Consecutive Patients in Europe: Results of the 
International SHAKESPEARE Registry 
Anselm K. Gitt, Martin G. Gottwik, Ricardo Seabra-Games, Jean-Pierre L. Bassand, 
Paolo Fioretti, David Hashdai, Keith Dawkins, Karl E. Siegler, Rudolf Schiele, Uwe 
Zeymer, Jochen Senges, SHAKESPEARE-Study-Group, Heruentrum Ludwigshafen, 
Ludwigshafen, Germany 
Background: In early 2001, the ACCIAHA Task Force on Practice Guidelines published 
revised guidelines for percutaneous coronary interventions (PCI). At this time, no data 
exist to help understand how these guidelines are implemented into clinical practice, 
especially the use of GP Ilb/llla receptor blockers (Ilb/llla). The SHAKESPEARE REGIS- 
TRY has been designed to fill this informational void. 
Methods: Since February 2002 consecutive patients undergoing PCI have been included 
in the International SHAKESPEARE tegistty to document clinical practice in 30 centers in 
different countries of the European Society of Cardnlogy (France, Germany, Israel, Italy, 
Portugal, UK). 
Results: Out of 3.117 consecutive patients undergoing PCI 1,796 patients (56%) had 
acute coronary syndromes (ACS), 19.5% acute STEMI, 7.6% acute NSTEMI, 30.3% 
unstable angIna, 1,251 patients (42%) underwent PCI for stable angma. Ilb/llla were 
given in 46% of the ACS patients and in 26% of the patients with stable angina. In 
patients with stable angina llblllla was given because the patients were considered high 
risk or because of technical difficult PCI. 
Conclusion: The use of llbillla was high in consecutive patients undergoing PCI for ACS 
with 22% even before the start of the intervention and 46% during the procedure. In con- 
secutwe patients undergoing PCI for stable angina Ilb/llla was given in only a minority 
before the intervention but in more than one quarter of the patients during the PCI proce- 
dure. 
Age (yean) 
Male gender 
Prior MI 
GP Ilb/llla before PCI 
Abclximab 
ACS 
(Il=1,798) 
64 
74.8 % 
19.9 % 
22.1 % 
7.4 % 
Stable Angina 
(n=l,251) 
64 
76.1 % 
32.4 % 
3.5 % 
1.3% 
P 
“s 
<O.Ol 
<O.Ol 
co.01 
co.01 
Tlrofiban 
3.7 % 0.9 % <O.Oi 
Eptifibatide 
10.9 % 1.8% co.01 
GP Ilb/llla during PCI 
Abciximab 
46.1 % 26.2 % co.01 
21.2 % 14.3 % co.01 
Tirofiban 
a.2 % 1.4% <O.Ol 
Eptifibatide 
10.7 % 6.3 % <O.Ol 
Stent 
Bleeding complication 
Hospital mortality 
75.7 % 74.6 % “s 
6.5 % 5.9 % <O.Ol 
2.9 % 0.4 % co.01 
1001-112 Prognostic Value of the Absolute Degree of ST-Segment 
Elevation of the ECG at Baseline and After Primary 
Angioplasty: Analysis From the CADILLAC Trial 
Eve D. Avmonq Michael G. McLaughlin, Peter Zimetbaum. Cindy L. Grines, James E. 
Tcheng, David A. Cox. Thomas D. Stuckey, Mark Turco, Eulogia Garcia, John J. Griffin. 
Roxana Mehran. Gregg W. Stone, The CADILLAC Investigators, Cardiovascular 
Research Foundation, New York, NY 
Background: In pts with AMI undergoing reperfusion therapy, ST-segment resolution 
(STR), as calculated by relative reduction of ST elevation (STE) from the pre to the post 
reperfusion ECG, has been found to correlate strongly with survival. Whether the &so- 
lute degree of STE on the pre and post ECG is prognostically important is undetermined. 
Methods: In CADILLAC, 2,062 pts were prospectively randomized to PTCA vs. stenting, 
each + abciximab. Paired ECGs withln 4 hours pre and post PCI with >l mm baseline 
STE without bundle branch block, paced rhythm, ectopy, missing leads or artifact were 
available in 700 patients and analyzed by an independent core ECG laboratory. 
Results: LAD infarction and lower baseline LVEF (p=O.Ol) were both associated with 
greater degrees of STE on the pre and post EGG. Additional correlates of residual STE 
on the post procedure ECG alone included hypertension, 3 vessel ds.. smaller reference 
vessel diameter, larger balloon to artery ratio, and pre and post TIMI O/l flow (~~0.05 for 
all). The incidence and impact of different degrees of pre and post PCI STE of l-year 
mortality appear in the table. 
Conclusions: The magnitude of ST elevation pre and post PCI are both strongly and 
continuously predictive of late modality after percutaneous intervention for AMI. In partic- 
ular, >2 mm of STE on the post PCI ECG (present I” nearly 1 in 6 pts) is a particularly 
ominous finding. The extent of STE should be considered when assessing baseline risk 
and the results of therapeutic interventions for AMI. 
STE pra PCI 
Incidence 
1 -year mortality 
STE post PCI 
lncldence 
l-year mortality 
1001-113 
<2mm 2to<3mm 3to<4mm 9mm Pvalue 
22% 26% 19% 31% - 
2.6% 3.1% 6.9% 7.5% 0.05 
<OSmm 0.5 to <l mm 1 to<2 mm >2mm P value 
32% 27% 25% 16% - 
3.2% 3.3% 4.6% 12.4% 0.0002 
Improved Efficiency in Both Initial Reperfusion Therapy 
and Subsequent Acute Myocardial Infarction Care 
Through Commitment to Emergency Department- 
Initiated Primary Percutaneous Coronary Intervention 
Jackson L. Thatcher, Theresa A. Gilseth, Susan Adlis, Park Nicollet Heart Center at 
Methodist Hospital, St. LOUIS Park, MN, Park Nicollet Institute, St. Louis Park, MN 
Study objective. Demonstrate improved efficiency of initial and subsequent in-hospital 
care followlng emergency department physician (ED)-initiated prxnary angioplasty 
(1’PCI) in ST-elevation infarction (STEMI). 
Methods. An observational study was undertaken comparing outcomes of patients 
receiving process improvement initiative supported. ED-directed 1’PCI to prior treatment 
by a mix of ED and cardiologist co-determined thrombolysis and I’PCI. 
Results.287 patients were treated. Median door-to-balloon time (MDBT) improved from 
68 to 61 minutes PdJ.0001). Necessary subsequent in-hospital interventions (PC1 or 
CAB) occurred in 65% of thrombolyiic patients, versus 3% of 1’PCI patients, and 1% 
I’PCI patients after process change (PC 0.0001). Median length of stay decreased from 
four days (thrombolytic) and three days (1’PCI) at baseline, to two days (1’PCI) postint- 
erventlon (P<O.OOOl). Improved effectiveness outcomes included beta-blocker: 63% to 
95% @0.0039), angiotensin-converting-enzyme inhibitor: 56% to 66% (P<O.OOOl), and 
antilipid therapy: 68% to 66% (F10.0039). Favorable trends occurred in survival (96.6%) 
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and 30.day major adverse cardiac events (MACE) (4.9%). 
Conclusions. ED-initiated 1’PCI for STEMI significantly improved efficiency of cars as 
measured by MDBT, need for subsequent in-hospital intervention. and length of stay. 
Effectiveness measures demonstrating improvement or favorable trends included dis- 
charge medications, survival and MACE. 
1001-208 Multivessel Percutaneous Intervention for ST-Segment 
Elevation Myocardial Infarction: The Mayo Clinic 
Experience 
Ali E. Denktaa James L. Orford, Panayotis Fasseas, Cem Barcin, Ryan J. Lennon, Amir 
Lerman, David R. Holmes, Jr., Mayo Clinic, Rochester, MN 
Introduction: The optimal treatment for patients presenting with ST segment elevation 
myocardial infarction (STEMI) with multiple critical s&noses is not established. In the cur- 
rent era of coronary stenting. with improved procedural outcomes, the simultaneous 
revascularization of multiple critical lesions may be a reasonable therapeutic strategy. 
Mathods: We performed a retrospective analysis of the Mayo Clinic cardiac catheteriza- 
tion laboratory database to compare procedural and clinical outcomes following percuta- 
neous coronary intervention (PCI) between 1995 and 2000 in patients with STEMI who 
underwent multivessel PCI (n=24) with others who underwent only infarct related artery 
(IRA) PCI (n=431). Results: Baseline variables were similar for the multivessel PCI and 
IRA PCI groups: the multivessel PCI group had significantly higher percentages of prior 
by-pass patients (21% vs. 8%, p=O.O4) and of Ilb/llla use (75% vs. 50%, p=O.O2). Proce- 
dural success was similar between the two groups (83% vs. 62%). Logistic regression 
analysis of procedural wccess adjusted for age, gender, and prior bypass surgery failed 
to show that multivessel intervention was a factor (OR 1.22. 95% Cl 0.63, 1.52; p=O.57). 
Mean follow-up of successfully treated patients was 2.2 + 1.5 years in the multivessel 
intervention group and 2.7 * 1.7 years in the single vessel intervention group (p= 0.21). 
The 3.year mortality was not different between the two groups (11.1% vs. 12.9% in the 
single vessel intervention group). Cox analysis of survival free of Ml or target vessel 
revascularizations adjusted for age, gender and the presence of prior by pass surgery 
showed a hazard ratio of 1.51 (95% Cl 0.76, 3.01; ~~0.24) for the multivessel PCI group. 
Conclusion: Multivessel PCI in STEMI was feasible and safe with similar procedural and 
long term clinical outcomes as compared with IRA PCI for patients with multiple critical 
lesions. Prospective, randomized studies evaluating this important clinical observation 
are necessary. 
1001-209 There Is Synergism of AspirinlHeparin With Low 
Frequency Ultrasound for Clot Lysis: Potential for 
Clinical Application in Acute Coronary Syndromes 
Shaul Atar Yoram Neuman, Takashi Miyamoto, Ming Chen, Huai Luo, Sergio Kobal, -I 
Robeti J. Siegel, Cedars-Sinai Medical Center, Los Angeles, CA 
Background: Aspirin (A) andior heparin (H) are commonly used in acute coronary syn- 
dromes and urgent coronary interventions. Low frequency high-intensity ultrasound 
(USD) has been proven to be efficacious and synergistic with various anti-thrombotic and 
fibrinolytic agents for in-vitro and in-viva clot lysis. However, there is currently little data 
on the possible synergism of aspirin with therapeutic USD for thrombus dissolution. 
Methods: Human blood clots from a single donor (n=l60, age 3-6 hours, mean weight 
316+23 mg) were incubated in normal saline and exposed to USD (27 kHz, 30 W, TIMl3, 
Santa Clara, CA) or no USD for 10 and 20 minutes. Clots were treated in solutions con- 
taining aspirin (Lysoprin, Rafa, Israel, lOOmgIL) alone, and in combination with heparin 
(1,000 U/L). The concentrations of A & H were similar to those used as loading doses in 
clinical practice. The absolute percent of clot weight reduction and the relative incremen- 
tal effect of USD exposure (D) were calculated. Results (Table). 
Conclusions: 1) low frequency high-intensity ultrasound significantly increases in-vitro 
clot lysis and is synergistic with aspwin alone or combined with heparin; 2) the highest 
incremental effect of ultrasound on clot lysis with the combination of aspirin and heparin; 
and 3) these findings suggest that transcutaneous low frequency ultrasound in combina- 
tion with ASA and/or heparin has potential in the treatment of acute coronary syndromes. 
lo’ saline 
20’ saline 
1o’A 
20’ A 
1O’AcH 
20’ A+H 
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No USD (n=80) 
31.4% 
40.0% 
29.0% 
39.6% 
26.3% 
37.0% 
USD (n=ElO) 
30.7% 
41 .O% 
34.1% 
44.8% 
36.1% 
48.5% 
Change p value 
.__ 0.32 
. . . 0.30 
17.6% 0.0052 
13.1% 0.0041 
37.3% 0.0009 
31.1% 0.00025 
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1002-093 Prevalence of Diabetes in Acute Coronary Syndromes: 
The Effects of Gender and Age 
Diane Wall Marwah Abdalla, Amy Arnold, Marcy Adlersberg, Barbara Gulanski, Teresa -I 
Caulin-Glaser, Investigators for The Ethel F. Donaghue Women’s Health Investigator 
Program at Yale, Yale University School of Medicine, New Haven, CT 
Background: Women with Acute Coronary Syndrome (ACS) are at significantly higher 
risk of coronary mortality than men with ACS, a difference that is most apparent in 
younger age groups. It has been hypothesized that diabetes mellitus (DM), a well-known 
risk factor for coronary disease and death, may contribute to the higher mortality rate in 
younger women with coronary artery disease (CAD). Although it has been demonstrated 
that women with CAD have significantly higher rates of DM than men. it is unknown 
whether this gender discrepancy in DM prevalence varies by age. We hypothesize that 
women age 30 - 74 years with ACS would have higher prevalence rates of known DM 
than men, and that this female predilection for diabetes would be most apparent in 
younger age groups. 
Methods: We prospectively reviewed 600 charts of patients age 30 - 74 years who were 
admitted to the Coronary Care Unit or General Cardiac Care Unit at Yale New Haven 
Hospital with suspected ACS, defined as unstable angina (UA) or myocardial infarction 
(Ml). ACS was confirmed in 314 patients whose charts were then examined for history of 
DM to determine whether prevalence varied by gender or age. 
Results: Of the 314 patients aged 30 74 years with confirmed ACS, women had signif- 
icantly higher rates of known DM than men (51% of women versus 27% of men, 
p<O.OOOl for ACS; 48% of women versus 20% of me”, pcO.0002, for Ml only). Further 
analysis revealed that the gender difference in DM prevalence was confined to patients 
below the age of 65. In this group, 53% of women with ACS had DM versus 21% of men 
(p<O.OOl), 48% of women with Ml had DM versus 13% of men (p=O.OOOl), and 60% of 
women with UA had DM versus 35% of men (p=O.O5). Above 65 years, gender differ- 
ences in the prevalence of DM were no longer significant. 
Conclusion: The prevalence of DM is significantly higher in women with CAD than men, 
and this gender difference is specific to patients below age 65 years. Whether the higher 
prevalence of DM in younger women contributes to their higher cardiac-related mortality 
requires further study. 
1002-l 00 Impact of High-Sensitivity C-Reactive Protein on Long- 
Term Mortality of Acute Myocardial Infarction in the 
Reperfusion Era 
Kunihiro Kinio, Hiroshi Sate. Hideyuki Sate, Yozo Ohnishi. Daisaku Nakatani, Hiroya 
Mizuno, Eiji Hishida, Masatsugu HOTI, Osaka University Graduate School of Medicine, 
Suita, Japan 
Background: Because C-reactive protein (CRP) measured shortly after the onset of 
acute myocardial infarction is associated with infarct size. prognostic value of CRP is 
controversial. However, reduction of CRP was accelerated by reperfusion and CRP 
peaked around 3 days after the onset. Therefore, CRP, which was measured at stable 
phase in acute myocardial infarction patients treated predominantly with reperfusion ther- 
apies, may be independent of infarct size and may predict long-term mortality. Purpose: 
To examine whether CRP levels, which were measured at stable phase, are associated 
with infarct size or not and to determine the impact of CRP on long-term mortality of 
acute myocardial infarction in the reperiusion era. Methods: We studied 1309 patients 
with acute myocardial infarction enrolled in Osaka Acute Coronary Insufficiency Study 
between April 1998 and Jun 2001. CRP was measured at 14 days or later (mean. 25 
days after the onset). The patients were followed for a mean 522 days. Results: Reper- 
fusion therapies were performed in 90.0% of patients. Patients in the highest quartile of 
CRP (XI.38 mgldl) were older, had higher prevalence of diabetes mellitus. and had 
higher Killip classes than patients in lower 3 quartiles (~0.38 mg/dl). Multivariate logistic 
regression analysis revealed that CRP was independently associated with age and 
absence of revascularization therapies but was not associated with peak CKZ3OOOlLVL. 
Patients in the highest quartile had higher long-term all-cause mortality and cardiovascu- 
lar mortality rates than patients in lower 3 quartiles (8.9% versus 2.0%, p<O.OOl; 6.4% 
versus 0.8%. p<O.OOl). Multivariate logistic regression analysis revealed that the highest 
quartile was an independent predictor of long-term all-cause mortality (odds ratio, 4.84; 
95% confidence interval, 1.37 to 17.1) and cardiovascular mortality (odds ratio. 10.8; 
